Former women’s world No. 1 Simona Halep has raised concerns over the perceived disparity in treatment by the International Tennis Integrity Agency (ITIA) in comparison to other players, notably Iga Swiatek and Jannik Sinner.
Swiatek recently accepted a one-month suspension for testing positive for trimetazidine, with the ITIA deeming her fault as minimal. In contrast, Halep faced a four-year ban for a doping violation involving Roxadustat, which was later reduced to nine months by the Court of Arbitration for Sport (CAS).
